NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at ...
Background and aims: Early onset neonatal sepsis due to vertical transmission of Group B streptococci (GBS) is responsible for severe morbidity and mortality of newborns. The aim of study was to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results